Self, W. H., Sandkovsky, U., Reilly, C. S., Vock, D. M., Gottlieb, R. L., Mack, M., Golden, K., Dishner, E., Vekstein, A., Ko, E. R., Der, T., Franzone, J., Almasri, E., Fayed, M., Filbin, M. R., Hibbert, K. A., Rice, T. W., Casey, J. D., Hayanga, J. A., Badhwar, V.
& 31 others,
Leshnower, B. G., Sharifpour, M., Knowlton, K. U., Peltan, I. D., Bakowska, E., Kowalska, J., Bowdish, M. E., Sturek, J. M., Rogers, A. J., Files, D. C., Mosier, J. M., Gong, M. N., Douin, D. J., Hite, R. D., Trautner, B. W., Jain, M. K., Jensen, J. U., Clausen, C. L., Hovmand, N., Pedersen, K. B., Thorlacius-Ussing, L., Tinggaard, M., Rastoder, E., Helleberg, M., Gerstoft, J., Lindegaard, B., Pedersen, T. I., Johnsen, S., Wiese, L., Knudsen, L. S. & ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group,
2022,
In: The Lancet Infectious Diseases. 22,
5,
p. 622-635 14 p.Research output: Contribution to journal › Journal article › Research › peer-review